With Sputum Test for SARS-CoV-2, MicroGen Dx Aims to Challenge Quest, LabCorp

Apr 03, 2020

|

The story has been updated to clarify that Quest and LabCorp's tests for the coronavirus were cleared for use with sputum samples.

NEW YORK – Although hundreds of labs across the US have been providing testing for SARS-CoV-2, Quest Diagnostics and Laboratory Corporation of America are the industry's leaders and have provided hundreds of thousands of tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

With Sputum Test for SARS-CoV-2, MicroGen Dx Aims to Challenge Quest, LabCorp

To read the full story....

Breaking News

AACC Issues Revised Guidance on Management of Point-of-Care Testing

In Brief This Week: Quest Diagnostics, Novacyt, Natera, and More

CDC Develops Test for Simultaneous Detection of COVID-19, Flu

Randox Laboratories Invests $33.7M to Increase Coronavirus Testing Capacity

Roche Garners FDA Emergency Use Authorization for Elecsys IL-6 Test in COVID-19 Patients

Immunovia Raises $43.0M Through Stock Issuance

Featured White Papers

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

What's Popular?

Beset by COVID-19 Pandemic, Europe Searches for Right Test Mix for Diagnosis, Surveillance

FDA Issues Emergency Use Authorizations for Gravity Diagnostics, Aspirus, CSI Coronavirus Tests

Mobidiag Receives CE Mark for Two PCR SARS-CoV-2 Tests

FDA Adds At-Home Self-Collection Template to SARS-CoV-2 Emergency Use Authorization Guidance

Sponsorships